Small Cell Lung Carcinoma (Small Cell Lung Cancer) Summary

Networked: 6172 relevant articles (423 outcomes, 1384 trials/studies) for this Disease

Key Drugs and Agents for Small Cell Lung Carcinoma

1. Etoposide (VP 16) : 84 outcomes 321 studies in 795 results : FDA 16 Generic
   
2. Cisplatin (Platino) : 61 outcomes 246 studies in 604 results : FDA 6 Generic
   
3. Carboplatin (JM8) : 38 outcomes 165 studies in 303 results : FDA 29 Generic
   
4. irinotecan (Camptosar) : 28 outcomes 111 studies in 216 results : FDA 19 Generic
   
5. Topotecan (Hycamtin) : 23 outcomes 84 studies in 176 results : FDA 6 Generic
   
6. Paclitaxel (Taxol) : 22 outcomes 85 studies in 131 results : FDA 13 Generic
   
7. Platinum : 15 outcomes 39 studies in 134 results : IBA
   
8. Doxorubicin (Adriamycin) : 11 outcomes 71 studies in 283 results : FDA 12 Generic
   
9. amrubicin : 11 outcomes 34 studies in 69 results : IBA
   
10. Cyclophosphamide (Cytoxan) : 9 outcomes 71 studies in 217 results : FDA 10 Generic
    

Diseases Related to Small Cell Lung Carcinoma

1. Neoplasms (Cancer)
2. Neoplasm Metastasis (Metastasis)
3. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
4. Lung Neoplasms (Lung Cancer)
5. Carcinoma (Carcinomatosis)

Key Therapies for Small Cell Lung Carcinoma

1. Drug Therapy (Chemotherapy) : 151 outcomes 381 studies in 1635 results
   
2. Radiotherapy : 49 outcomes 117 studies in 495 results
   
3. Cranial Irradiation : 35 outcomes 36 studies in 195 results
   
4. Combination Drug Therapy (Combination Chemotherapy) : 30 outcomes 62 studies in 271 results
   
5. Heterologous Transplantation (Xenotransplantation) : 6 outcomes 15 studies in 133 results